O016/#739 Outcomes of gynaecological cancer surgery during the COVID-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study

Fotopoulou, Christina; Khan, Tabassum; Braciník, J.; Glasbey, James; Abu‐Rustum, Nadeem R.; Chiva, Luis; Fagotti, Anna; Ghebre, Rahel; Gutelkin, Murat; Konney, Thomas Okpoti; Ng, Joseph Kee‐Yin; Pareja, René; Seenivasagam, Rajkumar; Sehouli, Jalid; Surappa, Shylasree; Bhangu, Aneel; Leung, Elaine Lai‐Han; Sundar, Sudha

doi:10.1136/ijgc-2022-igcs.18

Cited by 4 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic led to profound alterations in cancer care in Germany, similar to other countries [1, 9, 21]. The exceptional situation of a pandemic prompted precautionary measures, such as a strict lockdown during the first wave of the pandemic in March, April, and May 2020, and maintaining capacities for potential patients with COVID-19.…”

Section: Discussionmentioning

confidence: 99%

Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany

Lugnier,

Sommerlatte,

Attenberger

et al. 2024

Oncol Res Treat

View full text Add to dashboard Cite

In the context of the COVID-19 pandemic, there has been a scarcity of resources with various effects on the care of cancer patients. This paper provides an English summary of a German guideline on prioritization and resource allocation for colorectal and pancreatic cancer in the context of the pandemic. Based on a selective literature review as well as empirical and ethical analyses, the research team of the CancerCOVID Consortium drafted recommendations for prioritizing diagnostic and treatment measures for both entities. The final version of the guideline received consent from the executive boards of nine societies of the Association of Scientific Medical Societies in Germany (AWMF), 20 further professional organizations and 22 other experts from various disciplines as well as patient representatives. The guiding principle for the prioritization of decisions is the minimization of harm. Prioritization decisions to fulfill this overall goal should be guided by 1. the urgency relevant to avoid or reduce harm; 2. the likelihood of success of the diagnostic or therapeutic measure advised; and 3. the availability of alternative treatment options. In the event of a relevant risk of harm as a result of prioritization, these decisions should be made by means of a team approach. Gender, age, disability, ethnicity, origin and other social characteristics, such as social or insurance status, as well as the vehemence of a patient’s treatment request and SARS-CoV-2 vaccination status should not be used as prioritization criteria. The guideline provides concrete recommendations for 1. diagnostic procedures, 2. surgical procedures for cancer, and 3. systemic treatment and radiotherapy in patients with colorectal or pancreatic cancer within the context of the German healthcare system.

show abstract

Section: Discussionmentioning

confidence: 99%

Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany

Lugnier,

Sommerlatte,

Attenberger

et al. 2024

Oncol Res Treat

View full text Add to dashboard Cite

show abstract

“…1,2 Nonurgent medical care, and in some cases, cancer care, was postponed. 3 Urologists observed reduced cancer consultations and surgeries during this period, raising concern about treatment delays. 1,4,5 Testicular cancer serves as a particularly sensitive marker of this phenomenon as the clinical stage of testicular cancer at presentation is predictive of cancerspecific survival.…”

Section: Introductionmentioning

confidence: 93%

Restricted access and advanced disease in post-pandemic testicular cancer

Fagan,

Janes,

Andrews

et al. 2024

CUAJ

View full text Add to dashboard Cite

Introduction: Urologists observed reduced cancer consultations and surgeries during the SARS-CoV-2 pandemic, raising concern about treatment delays. Testicular cancer serves as a particularly sensitive marker of this phenomenon, as the clinical stage of testicular cancer at presentation is predictive of cancer-specific survival. We aimed to investigate whether COVID-related restrictions to primary care access resulted in increased incidence of metastatic germ cell testis cancer. Methods: A retrospective chart review was conducted on all cases of testicular cancer managed surgically at our center from March 1, 2018, to February 28, 2023. Patients were categorized into temporal cohorts, representing before, during, and following the implementation of COVID-19 public health restrictions in the province of Newfoundland and Labrador. Results: Forty-one cases of testicular germ cell tumors were identified during the study period. The mean age at diagnosis was 40.8 years (standard deviation ±13.7). Demographics did not vary across the cohorts. Clinical stage 3 disease remained stable before and during the pandemic at 10.5% and 9.1% of cases, respectively. In the post-pandemic period, there was an increase to 27.3% (p=0.617). Surgical wait times remained stable across the pandemic (p=0.151). Conclusions: There was a 16.8% rise in clinical stage III disease from the pre-pandemic to post-pandemic period. Our study failed to identify a statistically significant increase in metastatic testis cancer incidence upon lifting of pandemic restrictions. Further study is necessary to confirm suspicions that pandemic restrictions contributed to increased incidence of metastatic testis cancer.

show abstract

“…To date, several studies have been published on quality of care and psychosocial changes during the COVID-19 pandemic for various oncologic diseases. Two important factors leading to feelings of uncertainty among patients seem to be the fear of direct impact on one's health by infection with coronavirus in the presence of immunosuppression and the fear of receiving inferior oncologic treatment due to changes in the health care system [2,5]. Jacome, Deshmukh, Thulasiraman et al conducted a literature review of publications from around the world on the impacts of COVID-19 on ovarian cancer patients and found four main issues: delayed diagnosis, delayed treatment, alternative management (e.g., preference for oral therapies, virtual management), and reduced quality of life (higher rates of worry, depression, and anxiety) [6].…”

Section: Introductionmentioning

confidence: 99%

Predictors of quality of life and resilience in patients with ovarian cancer during the COVID-19 pandemic: a cross-sectional study

Schilling,

Toussaint,

Weigel

et al. 2024

Preprint

View full text Add to dashboard Cite

Purpose The aim of this cross-sectional study was to investigate the psychosocial burdens of patients with ovarian cancer during the COVID-19 pandemic. Methods Ninety-three patients diagnosed with ovarian cancer answered a quantitative survey during the COVID-19 pandemic assessing pandemic-related psychosocial impairment. The following domains, among others, were assessed: quality of life and therapy assessment (Functional Assessment of Cancer Therapy [FACT-G7]); anxiety (Generalized Anxiety Disorder Scale-7 [GAD7]); depression (Patient Health Questionnaire-2 [PHQ2]); global physical, mental, and social health (PROMIS items]); and resilience (Brief Resilience Scale [BRS]). Patient groups were compared via analyses of variance ([first-line treatment vs. second-line treatment vs. subsequent treatment] and [patients at younger age at start of treatment vs. older patients]) in terms of psychological impairment. Regression analyses were performed to predict preserved quality of life and resilience. Results Most patients rated their physical health, mental health, and satisfaction with social activities as good. Eighty-five patients (91.4%) were somewhat or very concerned about the pandemic. In general, patients on first-line therapy reported a better quality of life (p = 0.03) and better general health (p = 0.014) than those on at least second-line therapy. Patients who were younger at the start of treatment (< 65 years) reported significantly more concern about the pandemic than older patients (p = 0.008). Predictors of quality of life (FACT-7) were general health (global item), severity of depression (PHQ-2), and type of therapy. Predictors of resilience (BRS) were severity of anxiety (GAD-7) and mental health (global item). Conclusions Patients in the first line of treatment, and younger patients in particular, might benefit from support in coping with pandemic-related burdens. To ensure the highest possible resilience and quality of life in this patient group, attention should also be paid to potential psychological distress, which should be treated alongside the cancer.

show abstract

O016/#739 Outcomes of gynaecological cancer surgery during the COVID-19 pandemic: results from the international, multicenter, prospective covidsurg-gynaecological cancer study

Cited by 4 publications

References 0 publications

Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany

Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany

Restricted access and advanced disease in post-pandemic testicular cancer

Predictors of quality of life and resilience in patients with ovarian cancer during the COVID-19 pandemic: a cross-sectional study

Contact Info

Product

Resources

About